VKTX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 4.10%

Insider Buying (Last 12 Months): $29,946.00

Insider Selling (Last 12 Months): $84,832,228.79

Viking Therapeutics Insider Trading History Chart

Viking Therapeutics Share Price & Price History

^$27.94

▲ +2 (7.71%)

As of 04/29/2025 05:00 PM ET

Days: 30 | 90 | 365

Viking Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/31/2025	Sarah Kathryn Rouan	Director	Buy	1,240	$24.15	$29,946.00	1,240
1/6/2025	Brian Lian	CEO	Sell	194,490	$42.75	$8,314,447.50	2,366,570
1/6/2025	Greg Zante	CFO	Sell	50,309	$42.75	$2,150,709.75	165,259
1/6/2025	Marianna Mancini	COO	Sell	54,215	$42.75	$2,317,691.25	374,134
11/8/2024	Lawson Macartney	Director	Sell	2,000	$68.67	$137,340.00	47,965
10/28/2024	Greg Zante	CFO	Sell	131,687	$76.61	$10,088,541.07	149,366
10/25/2024	Sarah Kathryn Rouan	Director	Sell	11,000	$80.89	$889,790.00	9,500
9/20/2024	Brian Lian	CEO	Sell	216,130	$70.83	$15,308,487.90	2,304,927
9/20/2024	J. Matthew Singleton	Director	Sell	10,300	$69.50	$715,850.00	9,500
8/21/2024	Brian Lian	CEO	Sell	1,000	$69.90	$69,900.00	2,354,927
8/21/2024	J. Matthew Singleton	Director	Sell	5,700	$69.72	$397,404.00	9,500
8/19/2024	Brian Lian	CEO	Sell	112,870	$65.80	$7,426,846.00	2,354,927
8/19/2024	J. Matthew Singleton	Director	Sell	16,000	$62.22	$995,520.00	9,500
8/14/2024	J. Matthew Singleton	Director	Sell	20,786	$57.53	$1,195,818.58	9,500
7/30/2024	Brian Lian	CEO	Sell	115,859	$57.58	$6,671,161.22	2,354,927
7/30/2024	Marianna Mancini	COO	Sell	18,026	$57.13	$1,029,825.38	362,149
5/3/2024	Greg Zante	CFO	Sell	66,756	$74.69	$4,986,005.64	174,854
5/1/2024	Marianna Mancini	COO	Sell	281,425	$78.66	$22,136,890.50	348,508
2/8/2024	Brian Lian	CEO	Sell	269,079	$26.87	$7,230,152.73	2,184,882
2/8/2024	Sarah Kathryn Rouan	Director	Sell	25,000	$28.05	$701,250.00
1/30/2024	Brian Lian	CEO	Sell	35,000	$23.95	$838,250.00	2,264,882
1/19/2024	Sarah Kathryn Rouan	Director	Sell	30,000	$23.05	$691,500.00
1/4/2024	Greg Zante	CFO	Sell	15,000	$17.90	$268,500.00	180,730
5/16/2023	Charles A. Rowland, Jr.	Director	Sell	40,000	$25.00	$1,000,000.00	30,000
5/1/2023	Brian Lian	CEO	Sell	45,000	$22.45	$1,010,250.00	2,197,963
4/24/2023	Lawson Macartney	Director	Sell	16,000	$22.00	$352,000.00	47,965
4/19/2023	Brian Lian	CEO	Sell	35,000	$21.45	$750,750.00	2,242,963
4/17/2023	Brian Lian	CEO	Sell	155,000	$20.45	$3,169,750.00	2,277,963
4/17/2023	Greg Zante	CFO	Sell	7,500	$20.00	$150,000.00	149,279
4/17/2023	Lawson Macartney	Director	Sell	20,786	$20.00	$415,720.00	47,965
4/17/2023	Marianna Mancini	COO	Sell	12,500	$20.00	$250,000.00	287,763
4/13/2023	Brian Lian	CEO	Sell	79,336	$18.45	$1,463,749.20	2,307,963
4/11/2023	Greg Zante	CFO	Sell	56,295	$18.00	$1,013,310.00	149,279
4/3/2023	Brian Lian	CEO	Sell	22,000	$17.85	$392,700.00	2,232,963
4/3/2023	Greg Zante	CFO	Sell	30,911	$18.00	$556,398.00	147,778
3/31/2023	Brian Lian	CEO	Sell	67,970	$17.45	$1,186,076.50	2,254,963
3/30/2023	Greg Zante	CFO	Sell	131,029	$17.00	$2,227,493.00	147,778
3/29/2023	Marianna Mancini	COO	Sell	41,242	$16.00	$659,872.00	261,895

See Full Table

SEC Filings (Institutional Ownership Changes) for Viking Therapeutics (NASDAQ:VKTX)

76.03% of Viking Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Viking Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
4/29/2025	U.S. Capital Wealth Advisors LLC	35,751	$0.86M	0.0%	-19.1%	0.032%
4/29/2025	Financial Counselors Inc.	55,476	$1.34M	0.0%	+43.5%	0.049%
4/29/2025	Envestnet Asset Management Inc.	48,139	$1.16M	0.0%	+15.0%	0.043%
4/29/2025	Concurrent Investment Advisors LLC	9,102	$0.22M	0.0%	N/A	0.008%
4/29/2025	Bank of New York Mellon Corp	518,298	$12.52M	0.0%	+12.0%	0.462%
4/28/2025	Principal Financial Group Inc.	598,135	$14.45M	0.0%	-4.9%	0.533%
4/28/2025	Teacher Retirement System of Texas	26,989	$0.65M	0.0%	-8.6%	0.024%
4/25/2025	JNBA Financial Advisors	2,300	$56K	0.0%	N/A	0.002%
4/24/2025	CNB Bank	5,330	$0.13M	0.1%	+141.6%	0.005%
4/24/2025	HighMark Wealth Management LLC	4,660	$0.11M	0.1%	+9.4%	0.004%
4/23/2025	International Assets Investment Management LLC	27,584	$0.67M	0.0%	+50.9%	0.025%
4/23/2025	Oppenheimer & Co. Inc.	144,543	$3.49M	0.1%	+19.4%	0.129%
4/22/2025	Cambridge Investment Research Advisors Inc.	29,721	$0.72M	0.0%	+121.5%	0.026%
4/21/2025	Institute for Wealth Management LLC.	90,337	$2.18M	0.3%	+12.1%	0.080%
4/21/2025	MN Wealth Advisors LLC	18,628	$0.45M	0.3%	+215.7%	0.017%
4/18/2025	GSB Wealth Management LLC	8,317	$0.20M	0.1%	+12.2%	0.007%
4/17/2025	Janney Montgomery Scott LLC	39,529	$0.96M	0.0%	-7.2%	0.035%
4/17/2025	Exchange Traded Concepts LLC	33,218	$0.80M	0.0%	-3.7%	0.030%
4/16/2025	Farmers & Merchants Investments Inc.	12,625	$0.31M	0.0%	-7.5%	0.011%
4/16/2025	Compagnie Lombard Odier SCmA	20,245	$0.49M	0.0%	+286.0%	0.018%
4/15/2025	Handelsbanken Fonder AB	35,800	$0.87M	0.0%	-80.5%	0.032%
4/14/2025	Harbor Capital Advisors Inc.	115,189	$2.78M	0.1%	-10.9%	0.103%
4/14/2025	Wesbanco Bank Inc.	23,800	$0.58M	0.0%	+101.7%	0.021%
4/11/2025	Principia Wealth Advisory LLC	6,478	$0.15M	0.1%	+10.5%	0.006%
4/9/2025	RFG Advisory LLC	39,652	$0.96M	0.0%	N/A	0.035%
4/9/2025	NBC Securities Inc.	2,222	$53K	0.0%	+222,100.0%	0.002%
4/9/2025	Future Financial Wealth Managment LLC	2,350	$57K	0.0%	+1,242.9%	0.002%
4/9/2025	Profit Investment Management LLC	117,769	$2.84M	2.6%	+59.8%	0.105%
4/8/2025	Rhumbline Advisers	129,195	$3.12M	0.0%	-0.8%	0.115%
4/8/2025	Parallel Advisors LLC	1,363	$33K	0.0%	+64.8%	0.001%
4/7/2025	GAMMA Investing LLC	24,392	$0.59M	0.0%	+9,209.9%	0.022%
3/18/2025	California State Teachers Retirement System	93,794	$3.77M	0.0%	-0.6%	0.084%
3/13/2025	PKO Investment Management Joint Stock Co	15,000	$0.60M	0.1%	N/A	0.013%
3/11/2025	Lighthouse Financial LLC	14,000	$0.56M	0.5%	N/A	0.012%
2/24/2025	United Advisor Group LLC	5,812	$0.23M	0.0%	N/A	0.005%
2/19/2025	Formidable Asset Management LLC	30,872	$1.24M	0.2%	-7.5%	0.028%
2/19/2025	Public Employees Retirement System of Ohio	47,547	$1.91M	0.0%	+5.1%	0.043%
2/18/2025	Castleark Management LLC	4,978	$0.20M	0.0%	-85.8%	0.004%
2/18/2025	Mpwm Advisory Solutions LLC	4,217	$0.17M	0.1%	N/A	0.004%
2/18/2025	Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A.	267,464	$10.76M	1.3%	-45.9%	0.240%
2/17/2025	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	463,332	$18.64M	0.0%	-1.9%	0.416%
2/17/2025	Waverly Advisors LLC	48,369	$1.95M	0.0%	+34.6%	0.043%
2/17/2025	Woodline Partners LP	93,294	$3.75M	0.0%	+46.2%	0.084%
2/17/2025	Tang Capital Management LLC	320,000	$12.88M	0.9%	+166.7%	0.287%
2/17/2025	Tema Etfs LLC	20,215	$0.81M	0.3%	N/A	0.018%
2/17/2025	Second Line Capital LLC	49,511	$1.99M	0.5%	+29.9%	0.044%
2/17/2025	Sphera Funds Management LTD.	103,270	$4.16M	0.8%	-22.4%	0.093%
2/17/2025	Rafferty Asset Management LLC	271,163	$10.91M	0.0%	+6.9%	0.243%
2/17/2025	Raiffeisen Bank International AG	12,000	$0.48M	0.0%	N/A	0.011%
2/17/2025	Man Group plc	448,732	$18.06M	0.0%	+3,373.4%	0.403%
2/17/2025	Nuveen Asset Management LLC	319,868	$12.87M	0.0%	+0.6%	0.287%
2/17/2025	MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	10,797	$0.43M	0.0%	N/A	0.010%
2/17/2025	Integral Health Asset Management LLC	150,000	$6.04M	0.5%	-40.0%	0.135%
2/17/2025	Granahan Investment Management LLC	305,586	$12.30M	0.5%	-6.1%	0.274%
2/17/2025	Ethic Inc.	5,065	$0.20M	0.0%	N/A	0.005%
2/17/2025	Ensign Peak Advisors Inc	412,656	$16.61M	0.0%	-8.7%	0.370%
2/17/2025	FORA Capital LLC	27,744	$1.12M	0.1%	N/A	0.025%
2/17/2025	Fred Alger Management LLC	71,569	$2.88M	0.0%	-85.4%	0.064%
2/17/2025	Frontier Capital Management Co. LLC	597,739	$24.05M	0.2%	+2.8%	0.536%
2/17/2025	Deutsche Bank AG	6,427	$0.26M	0.0%	-70.4%	0.006%
2/17/2025	DAFNA Capital Management LLC	64,516	$2.60M	0.7%	-48.6%	0.058%
2/17/2025	Cetera Investment Advisers	86,181	$3.47M	0.0%	+7.0%	0.077%
2/17/2025	Boone Capital Management LLC	209,853	$8.44M	2.8%	+8.8%	0.188%
2/17/2025	Braidwell LP	1,479,666	$59.54M	1.8%	+27.9%	1.328%
2/17/2025	Cantor Fitzgerald L. P.	9,450	$0.38M	0.0%	N/A	0.008%
2/17/2025	Bamco Inc. NY	385,472	$15.51M	0.0%	-18.8%	0.346%
2/17/2025	Bellevue Group AG	12,939	$0.52M	0.0%	-20.0%	0.012%
2/17/2025	Bank of America Corp DE	361,551	$14.55M	0.0%	-14.5%	0.324%
2/17/2025	BNP Paribas Financial Markets	46,701	$1.88M	0.0%	-46.1%	0.042%
2/17/2025	Ameriprise Financial Inc.	1,479,596	$59.54M	0.0%	+228.5%	1.328%
2/17/2025	Apis Capital Advisors LLC	96,000	$3.86M	2.6%	+24.7%	0.086%
2/17/2025	Aptus Capital Advisors LLC	48,707	$1.96M	0.0%	+27.7%	0.044%
2/17/2025	5AM Venture Management LLC	189,593	$7.63M	1.8%	-20.2%	0.170%
2/17/2025	683 Capital Management LLC	280,000	$11.27M	0.7%	-12.5%	0.251%
2/14/2025	Freestone Grove Partners LP	5,572	$0.22M	0.0%	N/A	0.005%
2/14/2025	Comerica Bank	60,061	$2.42M	0.0%	-69.6%	0.054%
2/14/2025	Kapitalo Investimentos Ltda	1,568	$63K	0.0%	N/A	0.001%
2/14/2025	AQR Capital Management LLC	537,239	$21.52M	0.0%	+15.9%	0.482%
2/14/2025	Northern Trust Corp	535,984	$21.57M	0.0%	+11.4%	0.481%
2/14/2025	Beacon Pointe Advisors LLC	34,479	$1.39M	0.0%	+4.9%	0.031%
2/14/2025	Artia Global Partners LP	90,279	$3.63M	1.3%	-83.1%	0.081%
2/14/2025	Aquatic Capital Management LLC	209,134	$8.42M	0.2%	N/A	0.188%
2/14/2025	Oxford Asset Management LLP	7,428	$0.30M	0.2%	N/A	0.007%
2/14/2025	Gilder Gagnon Howe & Co. LLC	16,678	$0.67M	0.0%	N/A	0.015%
2/14/2025	Voya Investment Management LLC	390,140	$15.70M	0.0%	-42.1%	0.350%
2/14/2025	Syon Capital LLC	7,765	$0.31M	0.0%	N/A	0.007%
2/14/2025	Hood River Capital Management LLC	43,530	$1.75M	0.0%	-94.7%	0.039%
2/14/2025	Price T Rowe Associates Inc. MD	60,724	$2.44M	0.0%	-3.1%	0.054%
2/14/2025	Hsbc Holdings PLC	5,849	$0.23M	0.0%	-61.7%	0.005%
2/14/2025	IHT Wealth Management LLC	12,044	$0.49M	0.0%	-9.8%	0.011%
2/14/2025	J. Safra Sarasin Holding AG	13,710	$0.55M	0.0%	N/A	0.012%
2/14/2025	Stifel Financial Corp	178,819	$7.20M	0.0%	+36.1%	0.160%
2/14/2025	OneDigital Investment Advisors LLC	5,189	$0.21M	0.0%	+59.2%	0.005%
2/14/2025	Tower Research Capital LLC TRC	13,923	$0.56M	0.0%	+46.7%	0.012%
2/14/2025	MML Investors Services LLC	29,673	$1.19M	0.0%	+45.8%	0.027%
2/14/2025	Dimensional Fund Advisors LP	100,762	$4.06M	0.0%	-9.4%	0.090%
2/14/2025	Cornerstone Capital Inc.	24,800	$1M	0.1%	-16.7%	0.022%
2/14/2025	Altium Capital Management LLC	146,000	$5.88M	1.7%	+15.9%	0.131%
2/13/2025	CANADA LIFE ASSURANCE Co	83,579	$3.36M	0.0%	-0.8%	0.075%
2/13/2025	Osterweis Capital Management Inc.	155,445	$6.26M	0.3%	+23.8%	0.139%

Data available starting January 2016

See Full Table

Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trials to treat patients with biopsy-confirmed non-alcoholic steatohepatitis, as well as NAFLD. It also develops VK5211, an orally available non-steroidal selective androgen receptor modulator that is in Phase II clinical trials for the treatment of patients recovering from non-elective hip fracture surgery; VK0612, an orally available Phase IIb-ready drug candidate for type 2 diabetes; VK2735, a novel dual agonist of the glucagon-like peptide, which is in Phase 1 SAD/MAD clinical trial, and VK0214, an orally available tissue and receptor-subtype selective agonist of the TRß for X-linked adrenoleukodystrophy. The company was incorporated in 2012 and is headquartered in San Diego, California.

Today's Range

Now: $27.94

$26.57

$29.68

50 Day Range

MA: $26.27

$19.98

$34.07

52 Week Range

Now: $27.94

$18.92

$81.86

Volume

10,754,447 shs

Average Volume

4,091,179 shs

Market Capitalization

$3.14 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.84

Who are the company insiders with the largest holdings of Viking Therapeutics?: Viking Therapeutics' top insider shareholders include:
Brian Lian (CEO)
Marianna Mancini (COO)
Greg Zante (CFO)
Lawson Macartney (Director)
Charles A Rowland Jr (Director)
J Matthew Singleton (Director)
Sarah Kathryn Rouan (Director)
Learn More about top insider investors at Viking Therapeutics.
Who are the major institutional investors of Viking Therapeutics?: Viking Therapeutics' top institutional investors include:
Principal Financial Group Inc. — 0.53%
Bank of New York Mellon Corp — 0.46%
Oppenheimer & Co. Inc. — 0.13%
Rhumbline Advisers — 0.12%
Profit Investment Management LLC — 0.10%
Harbor Capital Advisors Inc. — 0.10%
Learn More about top institutional investors of Viking Therapeutics stock.
Which major investors are selling Viking Therapeutics stock?: In the previous quarter, VKTX stock was sold by these institutional investors:
Handelsbanken Fonder AB
Principal Financial Group Inc.
Harbor Capital Advisors Inc.
U.S. Capital Wealth Advisors LLC
Janney Montgomery Scott LLC
Teacher Retirement System of Texas
Exchange Traded Concepts LLC
Rhumbline Advisers
Within the last year, company insiders that have sold Viking Therapeutics company stock include:
Brian Lian (CEO)
Marianna Mancini (COO)
Greg Zante (CFO)
Lawson Macartney (Director)
Charles A Rowland Jr (Director)
J Matthew Singleton (Director)
Learn More investors selling Viking Therapeutics stock.
Which major investors are buying Viking Therapeutics stock?: Within the previous quarter, VKTX stock was purchased by institutional investors including:
Bank of New York Mellon Corp
Profit Investment Management LLC
RFG Advisory LLC
GAMMA Investing LLC
Oppenheimer & Co. Inc.
Financial Counselors Inc.
Cambridge Investment Research Advisors Inc.
Compagnie Lombard Odier SCmA